ANTICUERPOS ANTI-NUCLEOSOMA
Mexico·Clase II·III. DIAGNOSTIC AGENTS·BIO SIMEX, S.A. DE C.V.·Registered July 18, 2019PARA LA DETERMINACIÓN CUALITATIVA Y CUANTITATIVA DE ANTICUERPOS ANTI-NUCLEOSOMA EN SUERO O PLASMA HUMANOS.
FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF ANTI-NUCLEOSOME ANTIBODIES IN HUMAN SERUM OR PLASMA.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVOS PARA LA DETERMINACIÓN DE ANTICUERPOS ANTI-NUCLEOSOMA
- Trade Name (English)
- REAGENTS FOR THE DETERMINATION OF ANTI-NUCLEOSOME ANTIBODIES
- Analysis ID
- 1395R2019 SSA
- Registration Date
- July 18, 2019
- Name (Spanish)
- BIO SIMEX, S.A. DE C.V.
- Name (English)
- BIO SIMEX, S.A. DE C.V.
Access comprehensive regulatory information for ANTICUERPOS ANTI-NUCLEOSOMA (ANTI-NUCLEOSOME ANTIBODIES) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1395R2019 SSA and manufactured by BIO SIMEX, S.A. DE C.V.. The device was registered on July 18, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.